KFDA to raise preliminary review fees for clinical studies.
Published: 2002-02-20 06:58:00
Updated: 2002-02-20 06:58:00
The KFDA newly adopted the authorization system for the protocol of clinical studies, and plans to have its explanatory meeting for the R&D responsible members of the respective pharmaceutical firms at the KPMA auditorium at 3 p.m. on Feb. 19.
In the meeting the KFDA may explain the revised w...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
